首页> 外文OA文献 >Wavelet-based algorithm to the evaluation of contrasted hepatocellular carcinoma in CT-images after transarterial chemoembolization
【2h】

Wavelet-based algorithm to the evaluation of contrasted hepatocellular carcinoma in CT-images after transarterial chemoembolization

机译:基于小波的算法评估经动脉化疗栓塞后CT图像中对比的肝细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background: Hepatocellular carcinoma is a primary tumor of the liver and involves different treatment modalities according to the tumor stage. After local therapies, the tumor evaluation is based on the mRECIST criteria, which involves the measurement of the maximum diameter of the viable lesion. This paper describes a computed methodology to measure through the contrasted area of the lesions the maximum diameter of the tumor by a computational algorithm.Methods: 63 computed tomography (CT) slices from 23 patients were assessed. Non-contrasted liver and HCC typical nodules were evaluated, and a virtual phantom was developed for this purpose. Optimization of the algorithm detection and quantification was made using the virtual phantom. After that, we compared the algorithm findings of maximum diameter of the target lesions against radiologist measures.Results: Computed results of the maximum diameter are in good agreement with the results obtained by radiologist evaluation, indicating that the algorithm was able to detect properly the tumor limits. A comparison of the estimated maximum diameter by radiologist versus the algorithm revealed differences on the order of 0.25 cm for large-sized tumors (diameter > 5 cm), whereas agreement lesser than 1.0 cm was found for small-sized tumors.Conclusions: Differences between algorithm and radiologist measures were accurate for small-sized tumors with a trend to a small decrease for tumors greater than 5 cm. Therefore, traditional methods for measuring lesion diameter should be complemented non-subjective measurement methods, which would allow a more correct evaluation of the contrast-enhanced areas of HCC according to the mRECIST criteria.
机译:背景:肝细胞癌是肝脏的原发性肿瘤,根据肿瘤的分期涉及不同的治疗方式。局部治疗后,肿瘤评估基于mRECIST标准,该标准涉及对活损伤最大直径的测量。本文介绍了一种计算方法,可通过计算算法通过病变的对比区域测量肿瘤的最大直径。方法:评估了来自23位患者的63层计算机断层扫描(CT)切片。对未形成对比的肝脏和HCC典型结节进行了评估,并为此开发了虚拟模型。使用虚拟体模对算法的检测和量化进行了优化。之后,我们将目标病变的最大直径与放射线医生的测量结果进行了比较。结果:最大直径的计算结果与放射线医生评估的结果非常吻合,表明该算法能够正确检测出肿瘤限制。放射科医生与算法对估计的最大直径的比较显示,大型肿瘤(直径> 5 cm)的差异约为0.25 cm,而小型肿瘤的一致性小于1.0 cm。算法和放射科医生的措施对于小型肿瘤是准确的,而对于大于5 cm的肿瘤有减小的趋势。因此,传统的病变直径测量方法应作为非主观测量方法的补充,这将允许根据mRECIST标准更准确地评估HCC的造影剂增强区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号